DEAL RONALD E 4

4 · BB&T CORP · Filed Jun 21, 2012

Form 4

Period: 2012-06-20

Director

Transactions

Exercise/Conversion
Common Stock
2012-06-20$28.11/sh+4,269$120,002→ 15,496.793 total
Exercise/Conversion
Stock Option (right to buy)
2012-06-20−746→ 0 total
Exercise: $28.14From: 2003-06-30Exp: 2012-12-31→ Common Stock (746 underlying)
Exercise/Conversion
Stock Option (right to buy)
2012-06-20−4,269→ 0 total
Exercise: $28.11From: 2003-01-01Exp: 2012-07-01→ Common Stock (4,269 underlying)
Exercise/Conversion
Common Stock
2012-06-20$28.14/sh+746$20,992→ 16,242.793 total
Sale
Common Stock
2012-06-20$30.05/sh−5,015$150,716→ 11,227.793 total

Holdings

Stock Option (right to buy)
Exercise: $31.80From: 2005-06-30Exp: 2014-12-31→ Common Stock (990 underlying)
990
Stock Option (right to buy)
Exercise: $39.35From: 2006-02-22Exp: 2015-02-22→ Common Stock (3,050 underlying)
3,050
Stock Option (right to buy)
Exercise: $27.73From: 2012-02-22Exp: 2021-02-22→ Common Stock (3,221 underlying)
3,221
Stock Option (right to buy)
Exercise: $28.89From: 2004-06-30Exp: 2013-12-31→ Common Stock (778 underlying)
778
Stock Option (right to buy)
Exercise: $27.53From: 2005-01-01Exp: 2014-07-01→ Common Stock (5,953 underlying)
5,953
Stock Option (right to buy)
Exercise: $39.73From: 2007-02-21Exp: 2016-02-21→ Common Stock (6,272 underlying)
6,272
Common Stock
(indirect: By Spouse)
2,270
Stock Option (right to buy)
Exercise: $25.75From: 2004-01-01Exp: 2013-07-01→ Common Stock (5,244 underlying)
5,244
Stock Option (right to buy)
Exercise: $44.15From: 2008-02-20Exp: 2017-02-20→ Common Stock (4,672 underlying)
4,672
Stock Option (right to buy)
Exercise: $27.75From: 2011-02-23Exp: 2020-02-23→ Common Stock (4,285 underlying)
4,285
Stock Option (right to buy)
Exercise: $16.88From: 2010-02-24Exp: 2019-02-24→ Common Stock (7,722 underlying)
7,722
Stock Option (right to buy)
Exercise: $34.29From: 2009-02-26Exp: 2018-02-26→ Common Stock (5,797 underlying)
5,797
Common Stock
(indirect: By Trust)
31,960

Footnotes (9)

[F1]Includes 37.237 shares acquired May 1, 2012 under the Issuer's Dividend Reinvestment Plan.
[F2]The price in Column 4 is a weighted average price. The prices actually paid ranged from $30.050 to $30.061. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]The option is exercisable in five equal annual installments beginning on 2/20/2008.
[F4]The option is exercisable in five equal annual installments beginning on 2/21/2007.
[F5]The option is exercisable in five equal annual installments beginning on 02/22/2006.
[F6]The option is exercisable in four equal annual installments beginning on 2/22/2012.
[F7]The option is exercisable in four equal annual installments beginning on 02/23/2011.
[F8]The option is exercisable in five equal annual installments beginning on 02/24/2010.
[F9]The option is exercisable in five equal annual installments beginning on 2/26/2009.

Documents

1 file